Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

References for PMC Articles for PubMed (Select 19188609)

1.

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.

Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C.

Neurobiol Aging. 2010 Feb;31(2):224-43. doi: 10.1016/j.neurobiolaging.2008.04.002. Epub .

PMID:
18479783
2.

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior.

Selkoe DJ.

Behav Brain Res. 2008 Sep 1;192(1):106-13. doi: 10.1016/j.bbr.2008.02.016. Epub 2008 Feb 17. Review.

3.

18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.

Relkin NR, Szabo P, Adamiak B, Burgut T, Monthe C, Lent RW, Younkin S, Younkin L, Schiff R, Weksler ME.

Neurobiol Aging. 2009 Nov;30(11):1728-36. doi: 10.1016/j.neurobiolaging.2007.12.021. Epub 2008 Feb 21.

PMID:
18294736
4.

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, Mehta P, Craft S.

Neurology. 2008 Feb 5;70(6):440-8. Epub 2007 Oct 17. Erratum in: Neurology. 2008 Sep 9;71(11):866.

PMID:
17942819
5.
6.

Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.

Townsend M, Mehta T, Selkoe DJ.

J Biol Chem. 2007 Nov 16;282(46):33305-12. Epub 2007 Sep 13.

7.

Amyloid beta oligomers induce impairment of neuronal insulin receptors.

Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL.

FASEB J. 2008 Jan;22(1):246-60. Epub 2007 Aug 24.

8.

Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation.

Lee CC, Kuo YM, Huang CC, Hsu KS.

Neurobiol Aging. 2009 Mar;30(3):377-87. Epub 2007 Aug 10.

PMID:
17692997
9.

Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases.

Ferreira ST, Vieira MN, De Felice FG.

IUBMB Life. 2007 Apr-May;59(4-5):332-45. Review.

PMID:
17505973
10.

Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein.

Gr├╝nblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S.

J Neurochem. 2007 May;101(3):757-70.

PMID:
17448147
11.

Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease.

Landreth G.

Curr Alzheimer Res. 2007 Apr;4(2):159-64. Review.

PMID:
17430241
12.
13.

Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.

De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN, Bigio EH, Jerecic J, Acton PJ, Shughrue PJ, Chen-Dodson E, Kinney GG, Klein WL.

Neurobiol Aging. 2008 Sep;29(9):1334-47. Epub 2007 Apr 2.

14.
15.

Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine.

De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL.

J Biol Chem. 2007 Apr 13;282(15):11590-601. Epub 2007 Feb 16.

16.

Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.

Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL.

J Neurosci. 2007 Jan 24;27(4):796-807.

17.

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.

Haass C, Selkoe DJ.

Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12. Review.

PMID:
17245412
18.

AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.

Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R.

Neuron. 2006 Dec 7;52(5):831-43.

19.

Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency.

Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS.

Diabetes. 2006 Dec;55(12):3320-5.

20.

Monoclonal antibodies that target pathological assemblies of Abeta.

Lambert MP, Velasco PT, Chang L, Viola KL, Fernandez S, Lacor PN, Khuon D, Gong Y, Bigio EH, Shaw P, De Felice FG, Krafft GA, Klein WL.

J Neurochem. 2007 Jan;100(1):23-35. Epub 2006 Nov 20.

PMID:
17116235
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk